The clinical role of serum concentrations of selected cytokines: IL-1β, TNF-α and IL-6 in diagnosis of autoimmune thyroid disease (AITD) in children

References

• Rasmussen, A. K., K. Bendtzen, and U. Feldt-Rasmussen. 2000. Thyrocyte-interleukin-1 interactions. Exp. Clin. Endocrinol. Diabetes. 108: 67–71
   PubMedGoogle Scholar
• Shi, Y., H. Wang, Z. Su, et al. 2010. Differentiation imbalance of Th1/Th17 in peripheral blood mononuclear cells might contribute to pathogenesis of Hashimoto’s thyroiditis. Scand. J. Immunol. 72: 250–255
   PubMed Web of Science ®Google Scholar
• Bossowski, A., M. Moniuszko, M. Dabrowska, et al. 2013. Lower proportions of CD4+CD25(high) and CD4+FoxP3, but not CD4+CD25+CD127(low) FoxP3+ T cell levels in children with autoimmune thyroid diseases. Autoimmunity. 46: 222–230
   PubMed Web of Science ®Google Scholar
• Klatka, M., E. Grywalska, M. Partyka, et al. 2014. Th17 and Treg cells in adolescents with Graves’ disease. Impact of treatment with methimazole on these cell subsets. Autoimmunity. 47: 201–211
   Google Scholar
• Luu, V. P., M. I. Vazquez, and A. Zlotnik. 2014. B cells participate in tolerance and autoimmunity through cytokine production. Autoimmunity. 47: 1–12
   PubMed Web of Science ®Google Scholar
• Peng, D., B. Xu, Y. Wang, et al. 2013. A high frequency of circulating th22 and th17 cells in patients with new onset Graves’ disease. PLoS One. 8: e68446
   Google Scholar
• Gianoukakis, A. G., and T. J. Smith. 2004. The role of cytokines in the pathogenesis of endocrine disease. Can. J. Diabetes. 28: 30–42
   Google Scholar
• Rasmussen, A. K. 2000. Cytokine actions on the thyroid gland. Dan. Med. Bull. 47: 94–114
   PubMedGoogle Scholar
• Palczewska, I., and Z. Niedzwiedzka. 2001. Somatic development indices in children and youth of Warsaw. Med. Wieku. Rozwoj. 5: 18–118
   PubMedGoogle Scholar
• Phenekos, C., A. Vryonidou, A. D. Gritzapis, et al. 2004. Th1 and Th2 serum cytokine profiles characterize patients with Hashimoto’s thyroiditis (Th1) and Graves’ disease (Th2). Neuroimmunomodulation. 11: 209–213
   PubMed Web of Science ®Google Scholar
• Nanba, T., M. Watanabe, N. Inoue, and Y. Iwatani. 2009. Increases of the Th1/Th2 cell ratio in severe Hashimoto’s disease and in the proportion of Th17 cells in intractable Graves’ disease. Thyroid. 19: 495–501
   PubMed Web of Science ®Google Scholar
• Rebuffat, S. A., M. Kammoun-Krichen, I. Charfeddine, et al. 2013. IL-1beta and TSH disturb thyroid epithelium integrity in autoimmune thyroid diseases. Immunobiology. 218: 285–291
   PubMed Web of Science ®Google Scholar
• Diez, J. J., A. Hernanz, S. Medina, et al. 2002. Serum concentrations of tumour necrosis factor-alpha (TNF-alpha) and soluble TNF-alpha receptor p55 in patients with hypothyroidism and hyperthyroidism before and after normalization of thyroid function. Clin. Endocrinol. (Oxf). 57: 515–521
   PubMed Web of Science ®Google Scholar
• Pedro, A. B., J. H. Romaldini, and K. Takei. 2011. Changes of serum cytokines in hyperthyroid Graves’ disease patients at diagnosis and during methimazole treatment. Neuroimmunomodulation. 18: 45–51
   PubMedGoogle Scholar
• Salvi, M., M. Pedrazzoni, G. Girasole, et al. 2000. Serum concentrations of proinflammatory cytokines in Graves’ disease: effect of treatment, thyroid function, ophthalmopathy and cigarette smoking. Eur. J. Endocrinol. 143: 197–202
   PubMed Web of Science ®Google Scholar
• Lakatos, P., J. Foldes, C. Horvath, et al. 1997. Serum interleukin-6 and bone metabolism in patients with thyroid function disorders. J. Clin. Endocrinol. Metab. 82: 78–81
   PubMedGoogle Scholar
• Celik, I., S. Akalin, and T. Erbas. 1995. Serum levels of interleukin 6 and tumor necrosis factor-alpha in hyperthyroid patients before and after propylthiouracil treatment. Eur. J. Endocrinol. 132: 668–672
   PubMed Web of Science ®Google Scholar
• Siddiqi, A., J. P. Monson, D. F. Wood, et al. 1999. Serum cytokines in thyrotoxicosis. J. Clin. Endocrinol. Metab. 84: 435–439
   PubMedGoogle Scholar
• Wakelkamp, I. M., M. N. Gerding, J. W. Van Der Meer, et al. 2000. Both Th1- and Th2-derived cytokines in serum are elevated in Graves’ ophthalmopathy. Clin. Exp. Immunol. 121: 453–457
   PubMed Web of Science ®Google Scholar
• Pichler, R., W. Maschek, M. Hatzl-Griesenhofer, et al. 2003. Soluble tumour necrosis factor-alpha receptor I and interleukin-6 as markers of activity in thyrotoxic Graves’ disease. Horm. Metab. Res. 35: 427–433
   PubMedGoogle Scholar
• Kiziltunc, A., M. Basoglu, B. Avci, and I. Capoglu. 1999. Serum IL-6 and TNF-a in patients with thyroid disorders. Turk. J. Med. Sci. 29: 25–30
   Google Scholar
• Akalin, A., O. Colak, O. Alatas, and B. Efe. 2002. Bone remodelling markers and serum cytokines in patients with hyperthyroidism. Clin. Endocrinol. (Oxf). 57: 125–129
   PubMedGoogle Scholar
• Jiskra, J., M. Antosova, Z. Limanova, et al. 2009. The relationship between thyroid function, serum monokine induced by interferon gamma and soluble interleukin-2 receptor in thyroid autoimmune diseases. Clin. Exp. Immunol. 156: 211–216
   PubMedGoogle Scholar
• Aust, G., and W. A. Scherbaum. 1996. Expression of cytokines in the thyroid: thyrocytes as potential cytokine producers. Exp. Clin. Endocrinol. Diabetes. 104: 64–67
   PubMedGoogle Scholar
• Karanikas, G., M. Schuetz, K. Wahl, et al. 2005. Relation of anti-TPO autoantibody titre and T-lymphocyte cytokine production patterns in Hashimoto’s thyroiditis. Clin. Endocrinol. (Oxf). 63: 191–196
   PubMedGoogle Scholar
• Nielsen, C. H., T. H. Brix, R. G. Leslie, and L. Hegedus. 2009. A role for autoantibodies in enhancement of pro-inflammatory cytokine responses to a self-antigen, thyroid peroxidase. Clin. Immunol. 133: 218–227
   PubMed Web of Science ®Google Scholar
• Mori, K., K. Yoshida, M. Mihara, et al. 2009. Effects of interleukin-6 blockade on the development of autoimmune thyroiditis in nonobese diabetic mice. Autoimmunity. 42: 228–234
   PubMed Web of Science ®Google Scholar
• Ruggeri, R. M., S. Sciacchitano, A. Vitale, et al. 2009. Serum hepatocyte growth factor is increased in Hashimoto’s thyroiditis whether or not it is associated with nodular goiter as compared with healthy non-goitrous individuals. J. Endocrinol. Invest. 32: 465–469
   PubMed Web of Science ®Google Scholar
• Sieminska, L., C. Wojciechowska, B. Kos-Kudla, et al. 2010. Serum concentrations of leptin, adiponectin, and interleukin-6 in postmenopausal women with Hashimoto’s thyroiditis. Endokrynol. Pol. 61: 112–116
   PubMed Web of Science ®Google Scholar